• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMR
Click for more information
4.08% 51.0¢

IMRICOR MEDICAL SYSTEMS INC. - News & Media

Market Cap $128.7M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging... Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices, which is used to carry out real-time interventional Cardiac Magnetic Resonance Imaging (iCMR) cardiac ablation procedures. The Company is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The Company sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.More

Articles & Videos

Imricor raises $35M to pursue growth and expansion into Australia and NZ

Imricor Medical Systems Ltd intends to use the capital raising's funds to support a three-pronged growth strategy.

19 Jul 2024 12:45 (AEST)

Imricor (ASX:IMR) sees modest gains as company steps closer to EU trial

Imricor Systems' shares were up 2.17% in lunchtime trades on news the company is one step closer to launching a medical trial in Switzerland.

08 Mar 2024 12:39 (AEDT)

Imricor grows Middle Eastern operations with MRI heart tech to hit Qatar

Provider of interventional Cardiac Magnetic Resonance (iCMR) ablation medical hardware Imricor Medical Systems (ASX:IMR) has just expanded its Middle Eastern presence.

20 Dec 2023 13:46 (AEDT)

Imricor Medical Systems (ASX:IMR) partners with GE HealthCare for heart ablation procedures

Imricor Medical Systems (ASX:IMR) has partnered with global meditech giant GE Healthcare to perform real-time heart ablations using a mix of both companies' technologies.

27 Jan 2023 17:15 (AEDT)

US FDA gives Imricor Medical Systems (ASX:IMR) green light to begin VISABL-ALF trial

Imricor Medical Systems (ASX:IMR) has been granted Investigational Device Exception (IDE) approval from the US Food and Drug Administration (FDA) to begin a clinical trial in the United States.

24 Jan 2023 17:46 (AEDT)



(20min delay)
Last
51.0¢ 		Change
0.020(4.08%) 		Mkt cap ! $128.7M
Open High Low Value Volume
51.0¢ 52.0¢ 50.5¢ $65.06K 127.5K

Buyers (Bids)

No. Vol. Price($)
1 330 50.5¢
 

Sellers (Offers)

Price($) Vol. No.
51.0¢ 9330 1
View Market Depth
Last trade - 15.56pm 30/08/2024 (20 minute delay) ?
Last
51.0¢ 		  Change
0.020 ( 3.03 %)
Open High Low Volume
50.5¢ 52.0¢ 50.5¢ 23388
Last updated 15.56pm 30/08/2024 ?
IMR (ASX) Chart

Top Stories

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Tamboran (ASX:TBN) has spud the Shenandoah South 2H (SS-2H) well in permit EP 98, officially kicking off its Shenandoah South Pilot Project (SSPP) drilling program.
Helix investor makes partial takeover bid, proposing board changes A major investor in Helix Resources Ltd has offered to buy 25% of the company's shares, seeking to make changes to its board.
Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch The Consumer Staples sector's resilience across different market conditions makes it a compelling choice in a weaker economy.
Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues Wastewater industrial services player Vysarn (ASX:VYS) has announced its acquisition of competitor Waste Water Services Pty Ltd for $7.5M.
The Calmer Co’s Anthony Noble reflects on record breaking FY24 The Calmer Co’s MD & CEO, Anthony Noble, highlights the company’s impressive financial performance for FY24.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.